Australia's Neuren Pharmaceuticals rises to 1-1/2-year high on FDA Fast Track designation - TradingView

Reuters | Oct. 19, 2025, 8:46 p.m. | Original
Australia's Neuren Pharmaceuticals rises to 1-1/2-year high on FDA Fast Track designation TradingView
Verstappen's flawless US Grand Prix win tightens F1 title race - Reuters Australian Strategic Materials slumps on discounted placement - TradingView